Showing 2331-2340 of 2884 results for "".
- Study Links Personality Traits to Rhinoplasty Satisfactionhttps://modernaesthetics.com/news/study-links-personality-traits-to-rhinoplasty-satisfaction/2483320/A new study published in Aesthetic Plastic Surgery suggests a distinct relationship between personality traits and satisfaction with rhinoplasty outcomes. The study, titled “Rhinoplasty and the ‘Big Five’ Model: The Impact of Patients’ Personality Traits on Post-surgical Satisfac
- Thermage® FLX Exceeds 5 Million Skin Tightening Treatmentshttps://modernaesthetics.com/news/thermage-flx-exceeds-5-million-skin-tightening-treatments/2483284/Solta Medical, a subsidiary of Bausch Health Companies Inc., announced that more than 5 million Thermage® treatments have been performed worldwide, underscoring the global uptake of its skin tightening technology. Thermage® uses monopolar radiofrequency energy to heat skin layers and stimu
- Revance Brings Mepivacaine-Based Fillers to US Markethttps://modernaesthetics.com/news/revance-brings-mepivacaine-based-fillers-to-us-market/2483155/Revance has announced the US launch of the Teoxane RHA® Collection with Mepivacaine, marking a significant innovation in dermal filler formulations. The update reflects a shift in anesthetic agents used in hyaluronic acid fillers, with mepivacaine replacing lidocaine as the primary ane
- Oral GLP-1 Hits Phase 3 Trial Targets; Regulatory Submissions Cominghttps://modernaesthetics.com/news/oral-glp-1-hits-phase-3-trial-targets-regulatory-submissions-coming/2483149/Eli Lilly and Company announced positive topline results from its Phase 3 ATTAIN-2 trial, showing that its investigational oral GLP-1 receptor agonist, orforglipron, achieved significant weight loss and improved cardiometabolic outcomes in adults with obesity or overweight status and type 2 diabe
- Device Manufacturer’s Initiative Offers Treatments to Support Firefighters’ Healthhttps://modernaesthetics.com/news/device-manufacturers-initiative-offers-treatments-to-support-firefighters-health/2483123/BTL Industries has launched a nationwide initiative aimed at addressing the mental and physical health challenges faced by firefighters, particularly those serving in high-risk wildfire regions. The program is framed under BTL’s Heros Deserve Healing campaign, which calls on clinicians an
- Innovative Hair Transplant Technique Combines MSCs to Enhance Hair Growthhttps://modernaesthetics.com/news/innovative-hair-transplant-technique-combines-mscs-to-enhance-hair-growth/2483096/New research published in Aesthetic Plastic Surgery reveals an innovative technique that may advance the treatment of baldness. In the article “Regenerative Hair Transplant: Innovation in Hair Transplantation Regenerative® Hair Transplant” the authors concluded that combining hair transp
- Korean Skincare Brand Launches in US with Sensitive-Skin Formulationshttps://modernaesthetics.com/news/korean-skincare-brand-launches-in-us-with-sensitive-skin-formulations/2483054/South Korean skincare brand Hexkin has entered the US market, offering products formulated for sensitive skin using collagen-based and peptide-driven technologies, according to a press release. Rooted in traditional Korean sk
- New Website Streamlines Laser Therapy Device Selectionhttps://modernaesthetics.com/news/new-website-streamlines-laser-therapy-device-selection/2482984/ColdLasers.org has launched LaserTherapy.com, a redesigned platform aimed at simplifying the process of selecting therapeutic laser devices. The site offers a modern interface, comparison tools, and updated educational content designed to support informed decision-making. The platform addr
- Noninvasive Brain Stimulation for Mental Wellness Coming to Illinois Dermatology Clinichttps://modernaesthetics.com/news/noninvasive-brain-stimulation-mental-wellness-coming-illinois-dermatology-clinic/2482956/An Illinois dermatology clinic is now offering a noninvasive brain stimulation treatment for patients experiencing depression, anxiety, and related mental health concerns. Dundee Dermatology recently introduced EXOMIND, a transcranial magnetic stimulation (TMS) device that is FDA
- Regenerative Dermatology Company Forms Strategic Manufacturing Partnership with Innovigenhttps://modernaesthetics.com/news/regenerative-dermatology-company-forms-strategic-manufacturing-partnership-with-innovigen/2476008/Robles BioCeutics, a regenerative dermatology company focused on senolytic and stem cell-powered skincare, has entered a strategic manufacturing partnership with Innovigen, a California-based formulation and production company specializing in cosmetic GMP manufacturing. The agreement represents a